Ibrutinib, lenalidomide, and rituximab in relapsed or refractory mantle cell lymphoma (PHILEMON): A multicentre,...
Regimens based on ibrutinib alone and lenalidomide and rituximab in combination show high activity in patients with relapsed or refractory mantle cell lymphoma. We...
EvergreenHealth Implements UV Technology to Help Fight Infection-Causing Pathogens, Enhancing Hospital Safety
As part of its ongoing commitment to patient safety, EvergreenHealth has partnered with Clorox Healthcare to bring advanced ultraviolet light disinfecting technology to the...
AstraZeneca highlights latest advances in lung cancer at the ESMO 2017 Congress
At the European Society of Medical Oncology (ESMO) 2017 Congress in Madrid, Spain, 8-12 September, AstraZeneca and MedImmune, its global biologics research and development...
Fortis Hospital, Shalimar Bagh saves life of two middle-aged women suffering from recurrent malignant...
Team of doctors at Fortis Hospital, Shalimar Bagh led by Dr Surender Dabas, Director – Head, Neck and Thoracic Surgical Oncology recently performed two...
New Analysis Shows Repatha Reduces Cardiovascular Events In Patients With History Of Stroke
Amgen announced that a new analysis showed lowering low-density lipoprotein cholesterol (LDL-C) levels with Repatha® (evolocumab) reduced the risk of cardiovascular events in a...
Clinical research data sharing promises new cures and treatments
Clinical research generates extensive amounts of data, yet most of it is siloed or generally unavailable to a larger pool of willing potential researchers....
For the Critical Issue of Cancer-Related Financial Toxicity, Xcenda and Family Reach Collaborate
Xcenda consultants lent their scientific research, medical writing, and design expertise to collaborate on a white paper spearheaded by Family Reach, titled Cancer-Related Financial...
